Goldman Says Value, Not Cyclicals, Would Rally Most on Vaccine

(Bloomberg) -- Value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade, according to Goldman Sachs Group Inc.